Australia markets open in 2 hours 37 minutes
  • ALL ORDS

    7,543.60
    +7.50 (+0.10%)
     
  • AUD/USD

    0.7004
    -0.0090 (-1.27%)
     
  • ASX 200

    7,241.20
    +16.00 (+0.22%)
     
  • OIL

    66.22
    -0.28 (-0.42%)
     
  • GOLD

    1,782.10
    +21.40 (+1.22%)
     
  • BTC-AUD

    69,956.97
    -1,056.03 (-1.49%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     

Incyte to Report Third Quarter Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

WILMINGTON, Del., October 13, 2021--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, November 2, 2021.

The schedule for the press release and conference call/webcast is as follows:

• Q3 2021 Press Release:

November 2, 2021 at 7:00 a.m. ET

• Q3 2021 Conference Call:

November 2, 2021 at 8:00 a.m. ET

• Domestic Dial-In Number:

877-407-3042

• International Dial-In Number:

201-389-0864

• Conference ID Number:

13724199

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13724199.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 90 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005111/en/

Contacts

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Christine Chiou
+1 302 274 4773
cchiou@incyte.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting